Walter M. Stadler to Vincristine
This is a "connection" page, showing publications Walter M. Stadler has written about Vincristine.
Connection Strength
0.041
-
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019 06 01; 125(11):1830-1836.
Score: 0.041